Brilinta 60 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FZ4ZV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,673
Award facts
- Contract value 100% obligated
- $12,672.79 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a competitively competed delivery order valued at $12,672.79 to AmerisourceBergen Drug Corp for the delivery of Brilinta (ticagrelor) 60 mg tablets. The contract, awarded on January 29, 2026, with a completion date of January 30, 2026, operates under a firm fixed-price structure with no set-aside designation. Performance will occur at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive experience supplying a diverse range of pharmaceutical products across multiple therapeutic domains to defense and civilian healthcare agencies. Cencora, Inc. holds the parent IDC with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031, which encompasses specialty medications, brand-name and generic drugs, vaccines, and medical supplies supporting military treatment facilities and veterans' healthcare programs globally.
Quick answers
Who was awarded contract SPE2DR26FZ4ZV?
SPE2DR26FZ4ZV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FZ4ZV worth?
The government has obligated $12,673 on SPE2DR26FZ4ZV.
Is contract SPE2DR26FZ4ZV an order under another contract?
Yes. SPE2DR26FZ4ZV is a delivery order under SPE2DR25D1050, an indefinite delivery contract.
Was contract SPE2DR26FZ4ZV competed?
The extent of competition for SPE2DR26FZ4ZV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award